Apple is offering ‘buy now, pay later.’ 4 reasons to think twice before signing up

After months of speculation, Apple AAPL, -0.45% finally unveiled its buy now, pay later offering this week, wading into an industry that’s experienced explosive growth. But consumers should be wary of...

Apple Needs to Show Some Spark as Shoppers Favor Services Over Stuff

Customers at the Apple Store in Grand Central Terminal in New York City earlier this year. Getty Images Text size As Apple prepares to upgrade its products, there are two distinct trends hitting the e...

Biden open to canceling $10,000 in student loans per borrower — what that means for your budget, credit score and tax bill

If $10,000 vanishes from your student debt, you may want to celebrate. This is a question millions of student loan holders may be facing soon if President Joe Biden proceeds with a controversial plan ...

Relief at the Pump Could Come Soon. Thank Saudi Arabia.

Justin Sullivan/Getty Images Text size Oil prices fell Thursday after the Financial Times reported that Saudi Arabia was ready to increase output as more sanctions on Russia threaten global oil supply...

Hot stocks may bring an initial thrill, but they’ll break your heart

My father was born ​in 1936 in Brooklyn. He attended Erasmus High School, earned a degree in chemical engineering from Brooklyn Polytechnic High School and then went on to study dentistry at New York ...

‘The capitulation model for biotech is a Category 5 storm, the same as energy in 2020’ — why contrarians say the sector is a buy

If you want to know how much investors hate the biotech sector right now, consider this simple statistic: More than 25% of small biotech companies have stock-market capitalizations that are smaller th...

Stocks Are Ready for a Bounce Higher After S&P 500 Closes Above Bear Market

Text size Dreamstime The stock market came awfully close to finishing Friday in a bear market, at least 20% off its peak in early January. Many investors would like to see it get there so Wall Street ...

Novavax Gets a Sell Rating. It’s Got a Covid Vaccine Problem, Analyst Says.

Text size A healthcare worker prepares a dose of Nuvaxovid vaccine. Jeroen Jumelet/ANP/AFP via Getty Images Novavax stock was dropping Friday after receiving a Sell-equivalent rating — the first since...

15 stocks that have fallen at least 33% but by these measures are still standouts in their sectors

During a year in which more than half of the stocks in the S&P 500 Index have declined 10% or more, you have probably seen the term “oversold” being bandied about. But what does oversold really me...

Opinion: 12 stocks to consider for the next leg of the bull market

You may want to wait until the stock market turns up again before expending energy on trying to pick individual companies. That’s because, during bear markets, almost all stocks become correlated with...

Phillips 66, Electronic Arts, and 5 More Companies That Raised Their Dividend

Text size Phillips 66 raised its stock dividend this week. David Paul Morris/Bloomberg Phillips 66 , Cardinal Health , and Electronic Arts were among the U.S. companies that declared dividend increase...

BioNTech Earnings Top Forecasts on Strong Sales of Covid-19 Vaccine

Text size BioNTech is continuing to work with Pfizer on follow-on Covid-19 vaccines. (Photo by THOMAS LOHNES/AFP via Getty Images) BioNTech , the German biotech company, reported first-quarter earning...

Big Pharma Has Enough Cash to Buy All of Biotech. Why M&A Isn’t Happening.

Text size Late last year, Barron’s predicted a wave of deals, citing biotech companies’ cash holdings. Above, the plates used to print one-dollar bills. Alex Wong/Getty Images With biotech...

The Future of Transportation Is a Lot More Than Tesla. How to Invest.

We once thought the future of transportation meant George Jetson’s flying car. Instead, we got Elon Musk’s Tesla—the company and the electric car—whose twin successes jolted the global automotive indu...

This trader predicted the bond meltdown, tech selloff and oil’s surge. Here’s what she says is coming next.

Fade the Fed anyone? Stocks are headed south, following a big Wall Street rally stemming from perceptions Federal Reserve Chair Jerome Powell and co. may be less hawkish than markets think. A short-li...

Storied VC says investors are unlearning the lessons of the last bull market. Jeff Bezos says you should listen.

Investors are mustering some courage following the worst month since the pandemic, and Friday’s session that ended with the Dow DJIA, -2.77% tanking nearly 1,000 points and the S&P 500 SPX, -3.63%...

AbbVie, Gilead and 4 Other Defensive Healthcare Stocks With Big Dividend Yields

Text size An AbbVie bio safety hood Courtesy of AbbVie Deep into the second quarter of the year, stocks have yet to recover, and investors are seeking safety in defensive plays. One sector that’s bene...

Sierra Oncology Stock Soars After $1.9 Billion Takeover by GSK

Text size The deal comes ahead of GlaxoSmithKline’s planned spinoff of its consumer health division in July. AFP via Getty Images GlaxoSmithKline has agreed to buy U.S. rare cancer therapy compa...

Sierra Oncology Stock Soars After $1.9 Billion Takeover by GlaxoSmithKline

Text size AFP via Getty Images GlaxoSmithKline has agreed to buy U.S. rare cancer therapy company Sierra Oncology for $1.9 billion in cash, as it looks to boost its portfolio of new specialty medicine...

Goldman Sachs, JPMorgan, Delta, TSMC, and Other Stocks for Investors to Watch This Week

Text size Uncredited First-quarter earnings season begins this week, kicked off as always by results from several big banks. JPMorgan Chase reports on Wednesday, followed by Wells Fargo , Goldman Sach...

FinTech Looks Like a $1.5 Trillion Growth Market

Illustration by Elias Stein Text size Wells Fargo ’s Jeff Cantwell says the time to buy fintech stocks is now—14 of them. Cantwell has started coverage of the group with Overweight ratings for all. Th...

Russia war could further escalate auto prices and shortages

BMW has halted production at two German factories. Mercedes is slowing work at its assembly plants. Volkswagen, warning of production stoppages, is looking for alternative sources for parts. For more ...

Pfizer, Moderna and J&J Face Shareholder Pressure to Broaden Covid-19 Vaccine Access

Socially conscious investors and global-health activists are turning to shareholders to press Covid-19 vaccine manufacturers Pfizer Inc., Moderna Inc. and Johnson & Johnson to make more of their s...

Equifax, TransUnion and Experian will soon stop counting medical debt in credit reports — now, for the bad news

The nation’s three major credit bureaus say they are overhauling how they include medical debt in a consumer’s credit history. The agencies said the removal will result in nearly 70% of the medical de...

S&P 500 marks 1st death cross in 2 years as investors assess Russia-Ukraine ahead of Fed decision

Dow industrials barely gained on Monday, while the S&P 500 logged its first death cross in two years and the Nasdaq Composite slumped to its lowest since December 2020, as investors monitored Russ...

Portfolio manager with 50 years of experience shares 1970s bear-market lesson, and three stocks to buy now

A previous version of this column gave the incorrect date for the Fed policy decision. The story has been corrected. Investors looking at their screens this morning might feel a bit of relief, with oi...

After an Incredible Rally, Beware a Dead Cat Bounce

An oil tanker stands at an oil terminal Thursday at Wilhelmshaven, Germany. Getty Images Text size It has been a tough year for stocks. A rally on Wednesday seemed to promise some reversal of the tren...

Viatris stock slides 24% as analysts say sale of biosimilars to Indian partner removes key growth driver

Viatris Inc. said Monday it has agreed to combine its biosimilars portfolio with privately held Indian company Biocon Biologics Ltd. for up to $3.335 billion, as part of a broader overhaul of its busi...

Viatris to Sell Biosimilars Business for $3 Billion. Shares Tumble.

Viatris will sell the biosimilars business of the former Mylan to the Indian drugmaker Biocon for as much as $3.3 billion. Dreamstime Text size Viatris , the company formed in 2020 through a merger of...

Covid-19 Vaccine Makers Face a New Rival as GlaxoSmithKline and Sanofi Prepare to Enter the Ring

As new Covid-19 cases fall, the postpandemic vaccine market grows more interesting. On Wednesday, GlaxoSmithKline and Sanofi, two of the world’s largest vaccine makers, said they would submit a Covid ...

Lithium Americas Stock Jumps After a Bullish Call

Text size This photo taken on March 12, 2021, shows a worker with car batteries at a factory for Xinwangda Electric Vehicle Battery Co., which makes lithium batteries for electric cars and other uses,...

Novavax Stock Tumbles on Report That Vaccine Deliveries Are Lagging

Text size Novavax labs in Gaithersburg, Md. Andrew Caballero-Reynolds/AFP via Getty Images Novavax shares were plunging more than 15% Tuesday after the company acknowledged to Reuters that it has comp...